Literature DB >> 15295102

YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.

Eva Grönroos1, Alexei A Terentiev, Tanel Punga, Johan Ericsson.   

Abstract

The tumor suppressor p53 regulates cell-cycle progression and apoptosis in response to genotoxic stress, and inactivation of p53 is a common feature of cancer cells. The levels and activity of p53 are tightly regulated by posttranslational modifications, including phosphorylation, ubiquitination, and acetylation. Here, we demonstrate that the transcription factor Yin Yang 1 (YY1) interacts with p53 and inhibits its transcriptional activity. We show that YY1 disrupts the interaction between p53 and the coactivator p300 and that expression of YY1 blocks p300-dependent acetylation and stabilization of p53. Furthermore, expression of YY1 inhibits the accumulation of p53 and the induction of p53 target genes in response to genotoxic stress. YY1 also interacts with Mdm2 and the expression of YY1 promotes the assembly of the p53-Mdm2 complex. Consequently, YY1 enhances Mdm2-mediated ubiquitination of p53. Inactivation of endogenous YY1 enhances the accumulation of p53 as well as the expression of p53 target genes in response to DNA damage, and it sensitizes cells to DNA damage-induced apoptosis. Hence, our results demonstrate that YY1 regulates the transcriptional activity, acetylation, ubiquitination, and stability of p53 by inhibiting its interaction with the coactivator p300 and by enhancing its interaction with the negative regulator Mdm2. YY1 may, therefore, be an important negative regulator of the p53 tumor suppressor in response to genotoxic stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15295102      PMCID: PMC514451          DOI: 10.1073/pnas.0402283101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.

Authors:  Muyang Li; Christopher L Brooks; Foon Wu-Baer; Delin Chen; Richard Baer; Wei Gu
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

2.  Polyubiquitination of p53 by a ubiquitin ligase activity of p300.

Authors:  Steven R Grossman; Maria E Deato; Chrystelle Brignone; Ho Man Chan; Andrew L Kung; Hideaki Tagami; Yoshihiro Nakatani; David M Livingston
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

3.  The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.

Authors:  David Dornan; Harumi Shimizu; Lindsay Burch; Amanda J Smith; Ted R Hupp
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

Review 4.  Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Curr Opin Cell Biol       Date:  2003-04       Impact factor: 8.382

5.  Transcription factor YY1 functions as a PcG protein in vivo.

Authors:  Lakshmi Atchison; Ayesha Ghias; Frank Wilkinson; Nancy Bonini; Michael L Atchison
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

6.  Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality.

Authors:  M E Donohoe; X Zhang; L McGinnis; J Biggers; E Li; Y Shi
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

7.  Identification and characterization of murine mHAUSP encoding a deubiquitinating enzyme that regulates the status of p53 ubiquitination.

Authors:  Soo-Kyung Lim; Ju-Mi Shin; Yong-Soo Kim; Kwang-Hyun Baek
Journal:  Int J Oncol       Date:  2004-02       Impact factor: 5.650

8.  YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.

Authors:  Tatiana Yakovleva; Larissa Kolesnikova; Vladana Vukojević; Irina Gileva; Koichi Tan-No; Matthias Austen; Bernhard Lüscher; Tomas J Ekström; Lars Terenius; Georgy Bakalkin
Journal:  Biochem Biophys Res Commun       Date:  2004-05-28       Impact factor: 3.575

9.  Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation.

Authors:  Keiko Kurisaki; Akira Kurisaki; Ulrich Valcourt; Alexei A Terentiev; Katerina Pardali; Peter Ten Dijke; Carl-Henrik Heldin; Johan Ericsson; Aristidis Moustakas
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

10.  Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo.

Authors:  Jianyuan Luo; Muyang Li; Yi Tang; Monika Laszkowska; Robert G Roeder; Wei Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  83 in total

1.  In-cell fluorescence activation and labeling of proteins mediated by FRET-quenched split inteins.

Authors:  Radhika Borra; Dezheng Dong; Ahmed Y Elnagar; Getachew A Woldemariam; Julio A Camarero
Journal:  J Am Chem Soc       Date:  2012-03-28       Impact factor: 15.419

2.  Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation.

Authors:  Saptarsi M Haldar; Yuan Lu; Darwin Jeyaraj; Daiji Kawanami; Yingjie Cui; Sam J Eapen; Caili Hao; Yan Li; Yong-Qiu Doughman; Michiko Watanabe; Koichi Shimizu; Helena Kuivaniemi; Junichi Sadoshima; Kenneth B Margulies; Thomas P Cappola; Mukesh K Jain
Journal:  Sci Transl Med       Date:  2010-04-07       Impact factor: 17.956

3.  Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a.

Authors:  Qing-Rong Chen; Li-Rong Yu; Patricia Tsang; Jun S Wei; Young K Song; Adam Cheuk; Joon-Yong Chung; Stephen M Hewitt; Timothy D Veenstra; Javed Khan
Journal:  J Proteome Res       Date:  2010-12-23       Impact factor: 4.466

4.  Endoplasmic reticulum stress accelerates p53 degradation by the cooperative actions of Hdm2 and glycogen synthase kinase 3beta.

Authors:  Olivier Pluquet; Li-Ke Qu; Dionissios Baltzis; Antonis E Koromilas
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

5.  MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.

Authors:  Chuangui Wang; Alexey Ivanov; Lihong Chen; William J Fredericks; Ed Seto; Frank J Rauscher; Jiandong Chen
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

6.  p53 mediates the negative regulation of MDM2 by orphan receptor TR3.

Authors:  Bi-xing Zhao; Hang-zi Chen; Na-zi Lei; Gui-deng Li; Wen-xiu Zhao; Yan-yan Zhan; Bo Liu; Sheng-cai Lin; Qiao Wu
Journal:  EMBO J       Date:  2006-11-30       Impact factor: 11.598

Review 7.  Ubiquitin and ubiquitin-like modifications of the p53 family.

Authors:  Ian R Watson; Meredith S Irwin
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

8.  A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair.

Authors:  Su Wu; Yujiang Shi; Peter Mulligan; Frédérique Gay; Joseph Landry; Huifei Liu; Ju Lu; Hank H Qi; Weijia Wang; Jac A Nickoloff; Carl Wu; Yang Shi
Journal:  Nat Struct Mol Biol       Date:  2007-11-18       Impact factor: 15.369

9.  A computational analysis of binding modes and conformation changes of MDM2 induced by p53 and inhibitor bindings.

Authors:  Jianzhong Chen; Jinan Wang; Weiliang Zhu; Guohui Li
Journal:  J Comput Aided Mol Des       Date:  2013-11-22       Impact factor: 3.686

Review 10.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.